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Abstract 
Bioprinting technology shows potential in tissue engineering for the fabrication of scaffolds, cells, tissues and organs 
reproducibly and with high accuracy. Bioprinting technologies are mainly divided into three categories, inkjet-based 
bioprinting, pressure-assisted bioprinting and laser-assisted bioprinting, based on their underlying printing principles. 
These various printing technologies have their advantages and limitations. Bioprinting utilizes biomaterials, cells or 
cell factors as a “bioink” to fabricate prospective tissue structures. Biomaterial parameters such as biocompatibility, 
cell viability and the cellular microenvironment strongly influence the printed product. Various printing technologies 
have been investigated, and great progress has been made in printing various types of tissue, including vasculature, 
heart, bone, cartilage, skin and liver. This review introduces basic principles and key aspects of some frequently used 
printing technologies. We focus on recent advances in three-dimensional printing applications, current challenges 
and future directions.
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Background
The loss or failure of organs and tissues is a difficult 
and costly problem in healthcare. The limited supply 
of organs globally [1] has motivated research on tissue 
engineering, particularly the design of a cell-scaffold-
microenvironment to promote the regeneration of vari-
ous types of tissue, e.g., skin [2], cartilage [3], bone [4], 
tendon [5] and cardiac tissue [6].
Scaffolds are considered the key element for tis-
sue regeneration because they provide the necessary 
mechanical support and a physical structure for the 
transplanted cells to attach, grow and maintain their 
physiological functions. A suitable scaffold, such as a 
bone scaffold for tissue engineering, must have favorable 
biocompatibility or cytocompatibility to provide a surface 
for cells to adhere, proliferate, differentiate and secrete 
extracellular matrix (ECM). ECM contains abundant 
bioactive molecules, including glycosaminoglycans, col-
lagen, fibronectin and cytokines. Pore size and inter-
connectivity also play important roles in cell adhesion 
and migration, vascularization and new tissue ingrowth 
[7–11]. Thus, a fully satisfactory scaffold must simultane-
ously support the growth of different cell types and tis-
sues, each with specific mechanical properties, chemical 
gradients, cell populations, and geometric structures. 
However, conventional fabrication methods [12, 13] used 
for manufacturing three-dimensional (3D) scaffolds, such 
as electrospinning, fiber deposition, freeze-drying, gas 
foaming, and salt leaching, lack precise control of inter-
nal structural features and topology. Therefore, tech-
niques for the accurate fabrication of multifunctional 
scaffolds are needed. These complex design constraints 
limit the effectiveness of many current traditional meth-
ods, particularly when attempting to repair clinically rel-
evant injuries, organs, and other complex tissues.
Additive manufacturing (AM) technology is increas-
ingly recognized as a potential solution for construct-
ing complex interfacial tissue engineering scaffolds. 
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automated deposition of biological substances on a sub-
strate using computer-aided design/computer-aided 
manufacturing (CAD/CAM) technology. The working 
principle of AM is that objects can be created by adding 
material in a layer-by-layer manner, in contrast to con-
ventional machining, which removes material in a sub-
tractive manner [14]. 3D bioprinting is an important type 
of the AM technology which focus on printing bioactiv-
ity substance. Bioprinting can control the shape, size, 
internal porosity and interconnectivity of a tissue-engi-
neering scaffold (Fig.  1). Moreover, some types of bio-
printing technology are capable of fixed-point deposition 
of cells and biomolecules, such as DNA, Polycose® and 
cytokines. Micro-tissues, micro-organs or mimetic extra-
cellular matrix (mECM) can provide researchers with an 
effective strategy to study disease progression [15] and 
mechanisms of drug action [16, 17], in addition to appli-
cations in tissue or organ transplantation [18, 19].
3D bioprinting technology has attracted increasing 
attention based on its immense potential in the manu-
facture of tissue-engineering compounds. This review 
focuses on the key elements of 3D bioprinting technology 
used to fabricate very precise scaffolds and the applica-
tions of printing-specific modeling used in patient preop-
erative planning and the production of artificial tissues or 
organs for implantation. The article also discusses chal-
lenges and potential future directions.
Bioprinting technologies and their applications
We have summarized 3D printing techniques frequently 
utilized for scaffold fabrication, cell behavior studies and 
tissue repair (Table 1).
Inkjet‑based bioprinting
Inkjet-based bioprinting is a type of bioprinting technol-
ogy based on the conventional inkjet printing process 
with desktop inkjet printers. It is a noncontact printing 
process that deposits precise picoliter droplets of “bioink” 
onto a hydrogel substrate or culture dish under computer 
control. The common methods can be further classified 
into thermal and piezoelectric actuator methods based 
on the droplet actuation mechanism [20]. In thermal 
technology, ink droplets are generated by heating so that 
an inflated bubble forces the ink out of the narrow nozzle 
and onto the substrates (Fig. 2a). The localized tempera-
ture can reach hundreds of degrees in only a few micro-
seconds to generate pulse pressure [21]. This technology 
is inexpensive and has been used broadly [22, 23]. How-
ever, the droplets prepared using the thermal technol-
ogy are mixed, unordered and unequal in size. Because 
of frequent nozzle blockages, smooth printing is difficult. 
Shear and thermal stress also affect the viability of the 
cellular and protein inks [24]. In piezoelectric technol-
ogy, drops are generated by the transient pressure from 
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Fig. 1 General 3D bioprinting technical route
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technology, the piezoelectric method does not use heat 
and does not cause orifice clogging, allowing droplets to 
remain directional with regular and equal size [25, 26]. 
However, piezoelectric technology can cause damage to 
the cell membrane and cell lysis if used too frequently 
[27]. Greater than 90  % viability has been reported for 
piezoelectrically deposited mammalian cells, including 
human osteoblasts, fibroblasts, and bovine chondrocytes 
[26].
Scientists have made great progress in patterning mol-
ecules, cells and organs by inkjet printing. Molecules 
such as DNA have been successfully printed [28], facili-
tating studies of cancer pathogenesis and treatment. In 
addition, thermal inkjet printing has been demonstrated 
to be biocompatible with Chinese hamster ovary (CHO) 
cells and rat embryonic motoneurons [29]. Less than 8 % 
of CHO cells were lysed in the printing process, indicat-
ing that mammalian cells can be successfully printed by 
inkjet bioprinting and retain their functions, with good 
prospects for creating living tissue structures or organs. 
Further developments in bioprinting technology have 
resulted in advancements in the printing of functional 
blood vessels and heart valves. In 2015, Jana and Ler-
man studied the bioprinting of cardiac valves to solve 
clinical transplantation shortages. Cardiac constructs 
are complex and important, particularly the four valves 
of the heart. Although heart valves have been success-
fully printed, the functional requirements of elastic-
ity and physiological conditions remain to be fulfilled 
[24]. Similarly, in 2014, Duan B examined printing of 
blood vessels and observed drawbacks similar to those 
observed for bioprinted heart valves. Hydrogels, the 
main biomaterials used in inkjet bioprinting, are too soft 
to withstand normal physiological conditions [30, 31]. 
Thus, to successfully print organs that maintain good bio-
logical function in vivo, new biological materials that are 
more suitable for the human body must be developed to 
match the mechanical and biological properties of native 
organs.
Pressure‑assisted bioprinting and its applications
Pressure-assisted bioprinting (PAB) is based on extrusion 
to create desired 3D patterns and constructs. The bio-
materials used for printing are usually solutions, pastes, 
or dispersions [32] that are extruded by coordinating 
the motion of pneumatic pressure or plunger- or screw-
based pressure in the form of a continuous filament 
through a microscale nozzle orifice or a microneedle 
onto a stationary substrate. After layer-by-layer applica-
tion, complete 3D patterns and constructs are eventually 
formed (Fig. 2c).
The advantages of PAB technology include room tem-
perature processing, direct incorporation of cells and 
homogenous distribution of cells. PAB has been applied 
to the printing of cell and organs with confirmed reten-
tion of activity. Bioprinted cells include mouse pre-osteo-
blasts, human mesenchymal stem cells, endothelial cells, 
and osteogenic progenitors. Bioprinted cells have been 
used to repair ovine calvarial defects [33]. The feasibil-
ity of multicellular bioprinted constructs incorporating 
goat multipotent stromal cells (MPSCs) and endothe-
lial progenitor cells with retention of heterogeneous cell 
organization in the subcutaneous tissue of immunodefi-
cient mice and production extracellular matrix has been 
demonstrated. The multipotent stromal cells in the mul-
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Fig. 2 Common types of bioprinting methods. a Thermal inkjet-based bioprinting technology utilizes an electric current pulse that impulses the 
thin film resistor, then generates bubbles that create a pressure pulse that propels the ink droplet onto the substrates. b A piezoelectric transducer 
creates a pulse that creates transient pressure, resulting in droplet ejection. c Pressure-assisted bioprinting uses solutions, pastes, or dispersions as 
biomaterials, which are extruded by pressure in the form of a continuous filament through a microscale nozzle orifice or a microneedle. d Laser-
associated bioprinting consists of three parts: a pulsed laser source, a ribbon and a receiving substrate. The lasers irradiate the ribbon, causing the 
liquid biological materials to evaporate and reach the receiving substrate in droplet form
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structures, and the endothelial progenitor cells differenti-
ated into blood vessels. These results support the ability 
of multicellular bioprinted grafts to retain activity in vivo 
[34, 35].
Laser‑assisted bioprinting
Laser-assisted bioprinting (LAB) uses a laser as the 
energy source to deposit biomaterials onto a substrate. 
This technique usually consists of three parts: a pulsed 
laser source, a ribbon coated with liquid biological mate-
rials that are deposited on the metal film, and a receiv-
ing substrate [24]. The lasers irradiate the ribbon, causing 
the liquid biological materials to evaporate and reach the 
receiving substrate in droplet form. The receiving sub-
strate contains a biopolymer or cell culture medium to 
maintain cellular adhesion and sustained growth after 
transfer of cells from the ribbon (Fig.  2d). LAB mainly 
uses nanosecond lasers with UV or near-UV wavelengths 
as energy sources to print hydrogels, cells, proteins and 
ceramic materials [36, 37]. The resolution varies from 
pico- to micro-scale features and is affected by many fac-
tors: the thickness of the biological materials on the film, 
their rheological properties, the energy of the laser pulse, 
the wettability of the substrate, and the printing speed 
and organization of the structure [38, 39].
Researchers have demonstrated the feasibility of using 
laser-based technology to print cells, for example, human 
dermal fibroblasts, mouse C2C12 myoblasts, bovine pul-
monary artery endothelial cells (BPAECs), breast can-
cer (MCF-7) cells and rat neural stem cells [39–41]. In 
2013, Michael et  al. [42] successfully created Graftskin 
skin substitutes by utilizing LAB technology, a landmark 
event in the field of laser-assisted bioprinting. Fibroblasts 
and keratinocytes were used as the cell sources to fabri-
cate the skin constructs, which were subsequently trans-
planted into the skin folds of nude mice to perform an 
in  vivo evaluation. Eleven days later, the graft adhered 
well to the tissue around the skin wound. The keratino-
cytes proliferated and differentiated well and grew to the 
skin stratum corneum and basal layer. Compared with 
other bioprinting technologies, LAB has unique advan-
tages, including a nozzle-free, non-contact process, the 
printing of cells with high activity and high resolution, 
and the control of ink droplets and precise delivery char-
acteristics. Ink bubble dynamics, shear stress and laser 
pulse energy all play important roles in the bioprinting 
process [43–45].
Stereolithography
Stereolithography (STL) technology is a solid free-
form, nozzle-free technology that was developed in 
the late 1980s [46]. A liquid, photo-sensitive polymer 
formulation is solidified upon illumination. STL uses 
digital micromirror arrays to control the light intensity 
to polymerize light-sensitive polymer materials. This 
technique is mainly applied to fabricate structures from 
curable acrylics and epoxies. The number of photo-
crosslinkable polymers is increasing, and multiple resins 
can be used for one structure [32]. Digital light projection 
controls the printing process in this top-down system. 
Compared with other solid freeform techniques, STL has 
the highest fabrication accuracy, and an increasing num-
ber of materials can be used in this process. Furthermore, 
STL can print light-sensitive hydrogels layer-by-layer, 
and the total printing time depends only on the thickness 
of the structure [47].
However, in addition to these advantages, there are 
numerous restrictions, such as the lack of proper bio-
compatible and biodegradable polymers, harmful effects 
from residual toxic photocuring reagents, the inability to 
completely remove the supporting structure and the ina-
bility to form horizontal gradients in the constructs [46]. 
UV-sensitive photoinitiators were once used, although 
UV is harmful to cellular DNA and causes skin cancer. 
In 2015, Wang [47] investigated the use of customized 
visible light in a STL system, including a commercial 
beam projector and bioinks, a mixture of PEGDA, meth-
acrylated gelatin (GelMA), and eosin Y-based photoini-
tiator. They first described the detailed protocol of the 
visible light-based STL system and revealed the neces-
sity of an infrared ray (IR)-filtering water filter to the 
system. Their experimental results with NIH 3T3 cells 
demonstrated that this system with customized visible 
light could support the bioprinting of visible light-curable 
hydrogels with 50-μm resolution and high cell viability 
(∼85 %) for at least 5 days.
Key points of bioprinting
The goal of tissue engineering is to fabricate 3D artifi-
cial tissues or organs composed of a scaffold, cells and 
a microenvironment that mimics the real environment 
of the human body. As a highly effective and accurate 
method to fabricate artificial tissue in  vitro, printing 
achieves these three necessary components. This section 
will discuss the applications and limitations of the mate-
rials used in bioprinting, including biomaterials, cells and 
cell factors.
Parameters of biomaterials
In general, biomaterials can be categorized into a large 
variety of hydrogel, metallic, ceramic, polymeric and 
composite materials. The physical characteristics of 
biomaterials determines the optimal printing type. For 
example, low-viscosity materials are more attractive for 
bioprinting because cells can grow well in the low-pres-
sure environment [48]. Other material properties, such 
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as pore size and interconnectivity, also influence the 
encapsulated cells [49].
Biocompatibility
The biocompatibility of biomaterials is the first parameter 
to be considered when fabricating scaffolds and signifi-
cantly limits the number of suitable materials. Scaffold 
materials must accommodate the encapsulated cells and 
the recipient’s body. Thus, the implant must be cytocom-
patible and support cell growth, attachment, proliferation 
and migration but safe for the host and not cause severe 
inflammation or immunologic rejection.
Hydrogels are attractive materials for bioprinting 
because they are an enormous three-dimensional net-
work of polymer chains holding a mass of water. For the 
processing of physical hydrogels, a polymer network is 
expected to form from the physical junctions between 
hydrogel macromolecules. The use of some photo-initi-
ators and monomers during hydrogel crosslinking affects 
cell viability depending on radical concentration and the 
length of exposure [50]. However, more complex, func-
tional and biocompatible hydrogels can be fabricated 
using bioprinting technology. Wüst et  al. [51] reported 
the use of different amounts of HA to print a tunable 
alginate-gelatin hydrogel composite with a two-step 
crosslinking procedure. Human mesenchymal stem cells 
(hMSCs) were subsequently mixed with the hydrogel, 
and cell viability was detected. Approximately 85  % of 
the cells were still viable after 3 days of in vitro culture. 
This experiment demonstrated that adding HA to the 
hydrogel in different concentrations enhances mechani-
cal properties to match hard tissue reconstruction with 
no reduction in cell viability.
Porosity and interconnectivity
Pore shape, volume, size and geometry all directly affect 
the behavior of cells after adhesion to the scaffold. Dif-
ferent pore sizes in matrices can affect extracellular 
matrix development and are strictly correlated with cel-
lular organization, collagen I assembly, and mineraliza-
tion [52]. Porosity and interconnectivity play important 
roles in the ingrowth of surrounding tissues. Open and 
interconnected pores can allow oxygen and nutrients to 
be transported into the interior and eliminate the waste 
generated by cellular metabolism.
Domingos et al. [53] performed a systematic analysis of 
3D-printed scaffolds to determine the effects of pore size 
and geometry on hMSC viability. Three different filament 
distances (550, 650 and 750  μm) and filament patterns 
(0°/90°, 0°/60°/120° and 0°/45°/90°/135°) were designed to 
obtain complex internal geometries. Cells encapsulated 
in the structure with larger filament distances and fewer 
deposition angles behaved more actively. The results 
indicated the following: (1) cell adhesion, viability and 
proliferation were strongly influenced by the pore size 
and shape, whereby large quadrangular pores enhanced 
hMSC viability and proliferation; (2) cell morphology 
did not seem to be affected by pore topology, as demon-
strated by the investigation of the shape factor.
Mechanical properties
Physical parameters are an indispensable part of tissue 
engineering scaffolds, particularly for the regeneration 
of hard tissues, such as bones and cartilages. Appropri-
ate mechanical strength matching that of natural bones 
is very important. When artificial bones with high elas-
tic moduli are implanted in situ, they may produce stress 
shielding and hinder new bone formation. The mechani-
cal properties of human cortical and cancellous bone are 
generally described as in Table 2.
Ceramics [54–57] such as TCP, CaP, HA and SiO2 are 
widely used in bone tissue engineering because of their 
excellent mechanical properties, osteoconductivity and 
comparability with bones. Some examples of bioprinted 
ceramic materials are listed in Table 3.
Most material components of bioink are derived from 
current materials used in tissue engineering and limit 
the application of printed scaffolds. In addition to good 
biocompatibility, high porosity and matching mechani-
cal properties, the ideal material must have appropriate 
hydrophilicity, pH neutrality, and degradability without 
the formation of toxic macromolecules. Future develop-
ment of manufacturing technology will enable printing of 
biofunctional scaffolds that perfectly mimic the extracel-
lular matrix to provide cells with a microenvironment for 
adhesion, proliferation and directional differentiation.
Classification and ink formulations
A wide range of biomaterial inks which categorize poly-
mers, ceramics, hydrogels and composites have been 
Table 2 Characteristics of human cortical and cancellous bones
Bone type Porosity (%) Pore size (μm) Compressive strength (MPa) Young’s modulus (GPa)
Cortical bone 3–12 <500 130–225 3–30
Cancellous bone 50–90 500–1000 4–12 0.01–0.5
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developed in the printing technology [58]. Compared 
to polymer and ceramic, hydrogel inks have received 
much more attention, and significant progress have 
already been made to design novel ink formulations. A 
new 3D bioprinting technique called freeform revers-
ible embedding of suspended hydrogels (FRESH) has 
been introduced by Feinberg AW [59]. The innovation of 
this technology is what deposits and crosslinks one kind 
of hydrogel inks into another that can be considered as 
a support carrier. It has been successfully applied in the 
printing of human femurs, branched coronary arteries, 
trabeculated embryonic hearts and human brains [60].
The lack of diversity in “biomaterial inks” became bar-
riers to the widespread applications of 3D printing. UV 
light, chemical cross-linking, and high temperatures in 
the materials machining negatively impact most biologi-
cally activities. However, utilizing cellularized matrix gels 
lacked initial mechanical strength. The balance between 
structural strength and biocompatible processing is 
hard to satisfy scientists [61]. In the future, more bioac-
tive and more mechanically stable must be developed 
to ultimately serve as the “bioink” for bioprinting tissue 
constructs.
Bioprinting cells
Cell printing is the key element for the printing of tissue 
and organs. However, the choice of bioink materials is 
limited by the stringent printing conditions. The stiffness, 
functional groups, and surface morphology of biomate-
rials have a significant impact on cellular behavior. Cells 
are usually encapsulated in biodegradable hydrogels that 
mimic a tissue-like environment for building bioprinted 
ink [62]. The characteristics of hydrogels can protect the 
inner cells from the shear force generated in the print-
ing process and maintain their bio-functions, such as 
the self-renewal ability and multi-lineage differentiation 
potency of stem cells. The cytocompatibility of laser-
assisted cell printing technology with cells post-deposi-
tion was recently demonstrated, and this technique has 
been widely used for its high resolution and accuracy in 
single-cell deposition.
Viability of post‑printed cells
CHO and embryonic motoneuron cells [29] were first 
successfully deposited into pre-defined patterns in 2005. 
That study emphasized the need to study the biocom-
patibility of the inkjet printing process and the ability to 
encapsulate cells into bioink. The results were satisfac-
tory, and less than 8 % cell death was observed. Research-
ers [62] have successfully constructed HepG2-loaded 
GelMA hydrogels exhibiting high cell viability of greater 
than 95 % for at least 8 days. These achievements dem-
onstrated the possibility of bioprinting complex, cell-
laden hydrogel tissue constructs. Cells embedded in the 
hydrogels may remain in a non-proliferating state [63]. 
Neufurth et  al. used the calcium salt of polyphosphate 
Table 3 3D-printed ceramic materials for tissue engineering
Material Porosity and compressive 
strength
Biological properties Printing type References





45 % High compressive modulus and  
good drug delivery  
performance
Micro-droplet jetting [106]
CaSiO3 70 % and 7 MPa Enhanced cell attachment and  
osteogenic activity
3D printing [100]
CaCO3/SiO2 34 % and 47 MPa resulting in improved  
mechanical properties and  
good cell affinity
Laser-aided gelling (LAG) [107]
Sr–Mg doped TCP 4–12 MPa Increased osteons and,  
consequently, an enhanced  
network of blood vessel  
formation and osteocalcin  
expression
3D printing [108]
HA/PVOH (poly(vinyl)alcohol) 55 % and 0.88 MPa Osteoconduction and  
osteointegration in vivo
3D printing [109]
HSP bioceramic (hollow- 
struts-packed)
65–85 % and ~5 MPa Significantly improved cell  
attachment and proliferation;  
promotion of formation of new  
bone tissue in the center of the  
scaffolds
A modified coaxial  
3D printing
[110]
Page 8 of 15Li et al. J Transl Med  (2016) 14:271 
(polyp-Ca2+-complex) as a second layer on top of an 
inner sodium alginate hydrogel surface, which strongly 
promoted cell proliferation and enhanced the hydrogel 
mechanical strength.
Bioprinted cells maintain their proliferation and differ-
entiation abilities in vitro, an important step in the devel-
opment of tissue constructs. Lorber et  al. [64] reported 
that adult rat RGCs (retinal ganglion cells) and glia could 
be successfully printed by a piezoelectric inkjet print-
ing method. No significant differences in cell survival 
and outgrowth were observed between the non-printed 
control group and the printed group. Additionally, coat-
ing a glial substrate first and then printing RGCs on top 
enhanced the functional activity of the cells. Future goals 
include printing other cells of the retina, particularly the 
light-sensitive photoreceptors, with exciting implications 
for the printing of a functional retina.
Bioprinting stem cells
Stem cells, including embryonic stem cells (ESCs), 
BMSCs and ASCs, can be printed and patterned by 
precise deposition of picoliter (pl) volumes of fluid or 
laser-aided accurate localization. An important concern 
in stem cell printing is that the activity of stem cells, 
including proliferation and pluripotency, may change 
during the printing process. Levato et  al. [65] encap-
sulated MSCs in gelatin methacrylamide-gellan gum 
bioinks that combined bioprinting with microcarrier 
technology. This bioprinting approach allowed cells to 
be deposited internally with 90  % viability after 3  days, 
and the cells were induced to osteogenic differentiation, 
with increased expression of bone markers such as ALP 
and OCN. MSCs were submerged in perfluorotributyl-
amine (C12F27N) as a hydrophobic high-density fluid to 
be printed in the desired shape [66]. A printed vascu-
lar bifurcation maintained its shape and dimensions for 
more than 6 months.
In the laser-assisted field, MSCs [67] were printed 
based on laser-induced forward transfer (LIFT) for the 
construction of scaffold-free autologous grafts. The 
seed cells survived the complete printing procedure and 
maintained their ability to proliferate and continue dif-
ferentiating into the osteogenic lineage. Laser-induced 
jet formation and jet dynamics were explored using time-
resolved imaging [45]. Slow jets were unperturbed, with 
increased stability and retention of stem cells with very 
high viability and high resolution. Ultraviolet (UV) light 
used in traditional laser-assisted printing technology 
might be damaging to the cellular DNA. Lin et  al. [68] 
reported a visible light-based projection STL system that 
successfully incorporated hASCs in hydrogel scaffolds.
Single‑cell patterning
As bioprinting technology has developed, single-cell dep-
osition onto two-dimensional (2D) and into 3D environ-
ments has been used to explore cell behavior and monitor 
responses to growth, physical stimulation, cytokines and 
metabolite factors at the cellular level. A single-cell 
throughput system was also utilized to explore stem cell 
characteristics [69]. Based on the microdroplet through-
put, the authors isolated and patterned single cells from 
heterogeneous cell suspensions. The printed cells main-
tained high viability of greater than 95  %, and 11 stem 
cell markers (including Kit and Notch1) were collected 
and analyzed from the genomic information. In Ma et al.’s 
work [70], researchers utilized a laser-patterned method 
to control MSC alignment to create a parallel-aligned 
morphology and studied cardiogenic differentiation and 
contractile function. Single-cell arrays have been widely 
utilized in neural networks. Dinh et al. [71] constructed 
compartmentalized brain models with single-cell preci-
sion based on microfluidic methods.
Significant progress has been made in controlling print-
ing conditions to ensure minimal damage to cells and ade-
quately mimic the extracellular environment. However, to 
print tissue structures, different cell types must be placed 
in specific locations, and stem cell differentiation must be 
controlled to produce the desired cell types [14]. Organ 
printing remains a long-term goal, and micro-organ print-
ing has more potential in clinical applications. For exam-
ple, islet cells with secretory capacity account for only 2 % 
of pancreas cells. Printing these functional cells and rein-
troducing them into patients may allow patients without a 
complete pancreas to continue producing insulin.
Extracellular microenvironment
The extracellular microenvironment or niche provides 
various stimuli, such as physical, chemical and biologi-
cal factors, to direct cell adhesion, proliferation and dif-
ferentiation. Obvious effects on cell behavior have been 
confirmed by directly designing the surface morphology 
of scaffolds [72].
Biological molecules, including proteins and nucleic 
acids, have been successfully deposited with bioprinting 
technologies such as inkjet printing [14]. An advantage of 
inkjet printing is the ability to control the concentration 
gradient of internal ingredients using different bioink 
densities [73].
Growth factors such as BMP2, epidermal growth fac-
tor (EGF) and fibroblast growth factor 2 (FGF-2) have also 
been measured by molecular patterning. To print 3D arti-
ficial tissues, studies of 2D molecular arrays may provide 
clues about the function of growth factors in their niche.
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Advanced applications of bioprinted tissues 
and organs
Artificial tissues and organs are printed by depositing 
cells, biomaterials and molecules layer by layer. Bioprint-
ing has the advantage of good resolution of the input 
cells. Using this technology, great efforts have been 
made in developing bioprinting technologies to attempt 
to print blood vessels [74], hearts [75], bone [76], carti-
lage [77], kidneys [78], skin [79], nerves and other tissues 
(Table 4). Figure 3 shows that the bioprinting technology 
has a wide range of applications from the molecular level 
such as DNA and protein to organ level.
Blood vessel and heart printing
As the mode of transport for nutrition and metabolic 
waste, functional blood vessels play important roles in 
cardiovascular diseases [80] and the construction of arti-
ficial organs, particularly these with a rich blood supply. 
Advances in developmental biology and iconography 
have enabled significant progress in printing vascula-
ture in vitro. However, due to the unique functions and 
specific structures of the vasculature in different tissues, 
creating a vascular system remains a critical, unmet 
challenge.
Bioprinting enables the fabrication of network struc-
tures using hydrogels or other materials as bioink. Bertas-
soni et al. [81] successfully bioprinted a vascular network 
with GelMA, which improved metabolic transportation, 
cellular viability and the formation of endothelial mon-
olayers. Kolesky et al. [82] successfully co-printed multi-
ple materials with cells and vasculature using thermally 
reversible gelation to fabricate complex tissues.
In the printing of cardiac valves, tissue-engineered 
valve scaffolds are generally focused on the rebuilding of 
the aortic valve [24]. Researchers have performed exten-
sive studies of printing aortic valve structures with hydro-
gels [30, 31, 83]. Cell-laden, valve-shaped structures were 
printed with a high cell survival rate (greater than 90 %). 
However, bioink materials are deficient in flexibility and 
elasticity, and their mechanical characteristics still do not 
meet clinical needs.
Bone and cartilage tissue printing
Bone and cartilage regeneration is the most mature field 
utilizing printing technology because the composition of 
hard tissues is uncomplicated and is mainly composed of 
inorganic elements. A variety of biomaterials have been 
produced to construct bone and cartilage scaffolds by 
many manufacturing approaches, including gas foam-
ing [84, 85], salt leaching [86, 87] and freeze drying [88, 
89]. However, the structural and mechanical properties 
of artificial scaffolds can be more accurately controlled by 
3D bioprinting than by other technologies.
A cement powder system was recently fabricated 
containing HA and TCP as the ideal composition for 
human bone replacement to repair large defects [90]. 
The dimensional accuracy of the bioprinted scaffolds 
was greater than 96.5  %. In Gao’s work [91], hMSCs 
and nanoparticles of bioactive glass (BG) and HA were 
co-printed to control the spatial placement of cells. 
hMSCs encapsulated in this compound exhibited high 
cell viability (86.62  ±  6.02  %) and compressive modu-
lus (358.91 ± 48.05 kPa) after 21 days in culture. In Park 
et al. work [92], HA and Col-1 hydrogels printed as tis-
sue-mimetic structures were investigated independently 
to elucidate their effects on the behavior of chondrocytes 
and osteoblasts. Chondrocytes on HA hydrogels and 
osteoblasts on Col-1 hydrogels maintained better prolif-
erative capacity and cell function than chondrocytes on 
Col-1 hydrogels and osteoblasts on HA hydrogels.
Bioprinting has been a popular technology for the crea-
tion of cartilage tissue engineering scaffolds from a vari-
ety of materials, ranging from ceramics to nanomaterials. 
Markstedt et al. [77] developed a printable bioink using a 
combination of nanofibrillated cellulose and alginate with 
human chondrocytes as living soft tissue. The mixture 
exhibited excellent shear-thinning behavior and cell via-
bility of 86 % after 7 days of 3D culture. The high plastic-
ity of the ink allowed shapes resembling cartilage tissues, 
such as an ear and a meniscus, to be printed successfully.
Although printable scaffolds have been extensively 
applied in bone and cartilage tissue engineering, bioinks 
with suitable physical properties are still needed.
Skin
Skin protects the body from attack by foreign substances 
and maintains the integrity of the body. Many chronic 
diseases and burn wounds cause irreversible damage to 
skin, and thus bioprinting technology is particularly criti-
cal in the preparation of skin substitutes for transplanta-
tion to repair damaged skin.
The LAB technique has been applied to the printing 
of bio-skin. Michael et  al. [42] successfully created skin 
substitutes using LAB technology and transplanted them 
to skin wounds of nude mice. Eleven days later, the graft 
was able to adhere well to the tissue around the skin 
wound, and the cells in the graft were able to proliferate 
and differentiate. In 2014, Lee et  al. used keratinocytes 
and fibroblasts as materials to bioprint skin tissue. The 
resulting skin tissue had representative morphology and 
biology. The skin bioprinted by 3D technology was able 
to maintain its shape and had high flexibility, reproduci-
bility and culture throughput. In addition, cells that cause 
skin diseases can be added to the biomaterials, and skin 
tissue printed with pathogenic cells can be used to study 
the pathophysiology of skin diseases [93].
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Liver tissue printing
Compared to other organs, the liver has strong regen-
eration ability. Patients who require liver transplanta-
tion can receive lobes of liver from a healthy donor [94] 
or can also wait for their own liver tissue to regenerate. 
However, healthy donors are in short supply, and the 
regeneration period for self-liver tissue is long. Therefore, 
bioprinting of liver tissue by tissue engineering is particu-
larly important.
Many researchers have studied liver bioprinting. Pri-
mary hepatocytes and stem cell-derived hepatocytes 
have been used as the bioink to bioprint liver tissue [95]. 
Although the cells lose a certain amount of activity and 
functionality in the printing process, liver tissue con-
taining both cell types can be sustained for a period of 
time. In contrast to traditional printing technologies, 
3D printing technology can provide the exact size and 
shape of the liver suitable for the needs of patients with 
liver resection [96]. Recently, a new technique has been 
used to maintain cell activity and functionality for longer 
times [97]. The technique utilizes bioprinting technology 
to form structures called “canaliculi” that are similar to 
the liver hepatic cord. The primary hepatocytes and the 
“canaliculus” structures are cultured together in the col-
lagen matrix. Then, a biomimetic ECM system evaluates 
the activity and functionality of the primary hepatocytes 
on different ECM-based hydrogels [98]. After the activ-
ity and functionality of the primary hepatocytes have 
been confirmed, the cells can be maintained for 4 weeks. 
Further increases in cellular activity would facilitate 
expanded applications of bioprinted liver tissue. Chang 
et  al. [99] also demonstrated that multilayered tissues 
can be used as in  vitro 3D liver models. This multilay-
ered tissue contained rat and human hepatocytes, and 
the multilayered cellular architecture could be used as a 
liver analog to help detect drug toxicities and for other 
medical and biological testing. Thus, 3D bioprinted livers 
can be used not only for liver resection in patients and 
other liver surgeries but also for simulated liver experi-
ments in vitro.
The use of biological printing for the liver would have 
profound impact. Although some achievements have 
been made, hurdles must still be overcome, including 
cost and time, and the mechanical properties of printed 
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Fig. 3 The applications of bioprinting range from the molecular level to organ level
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Limitations of and future directions for bioprinting
Different types of 3D printing are utilized for applications 
that range from studies of cellular behavior to investiga-
tions of tissue pharmacodynamics or toxicological mech-
anisms. Although 3D printers have high precision and 
reproducibility, printing organs and functional tissues 
with entire structures still requires assembly layer-by-
layer with “bio-glue.” The main technological barriers are 
suitable bioinks with good biocompatibility and mechan-
ical strength that can be used to achieve biological func-
tion. Hydrogels and ceramics have been used for soft and 
hard tissue engineering, respectively [50, 55, 100]. Mean-
while, personalized 3D printing technology will lead to 
a series of regulatory hurdles referring to the specified 
printed product supervision. However, it is urgent for the 
management establishing and perfecting relevant laws 
and regulations to guarantee sustainable development 
of 3D printing technology. Studies in the near future will 
likely bring great progress in printing micro-organs, such 
as pancreas islet tissues that function in the absence of 
the complete pancreas structure, which will benefit hun-
dreds of millions of diabetic patients around the globe. 
Chang [101] successfully fabricated micro-livers that 
were utilized for testing drug metabolism.
As printing technology develops, additional biomi-
metic, tissue engineered organs will be created. Decreases 
in reestablishment time and cost should also be addressed 
before bioprinting of organs can be applied in the clinic.
Conclusions
Bioprinting technology has drawn more and more atten-
tion as a fabrication methodology for producing scaf-
folds, cells, tissues and organs. It has advantages in 
precise control, repeatability and individual design, yet 
many challenges remains for building complex tissues 
including multiple cell types in a spatial structure. More 
importantly, bioink materials development, resolution 
enhancement and vascularization are necessary to apply 
bioprinting technology clinically.
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